While antifungal treatment with amphotericin B alone was not effective to mitigate secondary aspergillosis after CLP, adjunct anti-PD-1 treatment significantly improved 20-day survival and strongly reduced the fungal burden in brain, lung, and kidney tissues (46). The gene discussed is PDCD1; the disease is aspergillosis.